Presentations for Diagnosis

Moderated by Tom Hoffmann, MD – IWMF Trustee, 2019 Ed Forum
Researchers and clinicians answer, and sometimes debate, questions from the audience

Edward Stadtmauer, MD – University of Pennsylvania, 2019 Ed Forum
Reviews the diagnostic criteria, manifestations of the disease, International Staging System for prognosis for WM, diagnoses that can be confused with WM, why everyone is not treated at diagnosis, guidelines for initiation of therapy, and therapeutic landscape of WM, including the multiple treatment options for WM, plus new treatments on the horizon, and challenges in providing treatment.

Jeffrey Matous, MD -Colorado Blood Cancer Institute, 2019 Ed Forum
Prepares the newly diagnosed patient to get the most out of the other videos from this Educational Forum and provides a refresher course for veteran WM’ers

Jeffrey V, Matous MD, Colorado Blood Cancer Institute, 2018 Ed Forum
Explains how blood tests are used in patients with WM, what results mean, and which tests are important to track the disease

Guy Sherwood, MD, IWMF Vice President for Research, Moderator 2017 Ed Forum
Researchers and clinicians answer, and sometimes debate, questions from the audience

Ron Ternoway, Support Group Leader from Nova Scotia, 2017 Ed Forum
Provides the patient’s perspective about living with cancer and participating in clinical trials for WM

Toni Dubeau, RN, NP, Dana Farber Cancer Institute, 2017 Ed Forum

Jonas Paludo, MD – Mayo Clinic Rochester, 2017 Ed Forum
Reviews the clinical presentation and outcomes of young patients with WM

Peter DeNardis – IWMF Trustee, 2017 Ed Forum
Provides the patient’s perspective about living with cancer upon diagnosis of WM

Robert Kyle, MD - Mayo Clinic, Rochester, IWWM9 Doctor-Patient Forum, 2016

Morton Coleman, MD – Weill Cornell Medical College, 2016 Ed Forum
Discusses the frequency of various lymphoma subtypes in adults, with emphasis on WM and cancer drug development and reviews the signaling pathways in WM, drugs that inhibit WM cell survival and discusses the challenges of combining drugs and limiting side effects

Jorge Castillo, MD - Dana-Farber Cancer Institute, 2016 Ed Forum
Reviews the manifestations of WM disease, NCCN guidelines for initiation of treatment for WM, single agent treatments, combination therapies, maintenance, and new directions, including frontier clinical trials at Dana Farber Cancer Institute

Jeffrey Matous, MD, & Megan Andersen, NP-C - Colorado Blood Cancer Institute, 2016 Ed Forum
Prepares the newly diagnosed to get the most out of the other videos and provides a refresher course for veteran WM’ers

Robert Kyle, MD – Mayo Clinic, Rochester, Moderator, 2015 Ed Forum
Noted researchers and clinicians answer and sometimes debate questions from the audience

Larry Anderson, MD, PhD - University of Texas Southwestern Medical Center, 2015 Ed Forum
Covers diagnosis of WM (aka LPL) and treatment options

Joseph Mikhael, MD, MEd - Mayo Clinic, Arizona, 2015 Ed Forum
Reviews the basics of Waldenstrom’s Macroglobulinemia and how it is distinguished from myeloma and lymphoma.
Discusses the importance of an accurate diagnosis in WM.
Highlights the critical features to establish the need to treat WM.
Outlines the overall approach to therapy of WM.
Empowers you for the rest of this conference and your disease “career.”

Robert Kyle, MD – Mayo Clinic, Rochester, Moderator, 2014 Ed Forum
Noted researchers and clinicians answer and sometimes debate questions from the audience

Robert Kyle, MD - Mayo Clinic, Rochester, 2014 Ed Forum
Provides insight into IgM MGUS and smoldering WM, expected progression rates, risk factors for progression, no treatment unless symptomatic or when significant anemia develops

Richard Baz, MD - Moffitt Cancer Center, 2014 Ed Forum
Reviews general hematology and immunology, WM, and provides understanding of your laboratory work and response assessment